Pharmaceutical Beta Bionics Shares Edge Higher After Q4 Revenue Jumps 57%, Full-Year Sales Top $100 Million 4 weeks ago Shares of Beta Bionics, Inc. (Nasdaq: BBNX) were trading modestly higher in late morning U.S. trading on Wednesday, up about… Moderna Reports 4Q Revenue Of $678 Million, Projects 2026 Growth 1 month ago Moderna Inc. (NASDAQ: MRNA) reported fourth-quarter 2025 revenue of $678 million, a 30% decrease from $966 million in the same… Karyopharm Therapeutics Inc Shares Rise After Q4 2025 Results 1 month ago Karyopharm Therapeutics Inc (NASDAQ: KPTI) Shares closed at $6.31 on the Nasdaq in the most recent session, reflecting an intraday… Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance 1 month ago Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year increase driven by demand for… AptarGroup, Inc. (ATR) Shares Rise on Q4 Revenue Beat Amid Margin Pressure 1 month ago Shares of AptarGroup, Inc. (ATR) advanced modestly following the release of fourth-quarter and full-year 2025 results on February 5, 2026,…